Posted on 12/22/20
Pfizer and BioNTech's Coronavirus Vaccine Approved in Europe
Fresh off receiving its crucial emergency use authorization (EUA) in the U.S., Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) coronavirus vaccine has received similar approval in Europe.Both companies . . .
Posted on 12/22/20
Novavax: The COVID-19 Play Is Still Intact
SummaryNovavax's COVID-19 vaccine has shown efficacy in clinical trials. Late-stage trials could commence within days.NVAX's vaccine can be stored at refrigerated temperatures. Mass doses could potentially . . .
Posted on 12/22/20
Etsy: A COVID E-Commerce Winner That Will Keep Winning In 2021
SummaryEtsy benefitted from the COVID driven e-commerce boom, but the company is well positioned for continued success in 2021.Company boasts several important competitive advantages: unique assortment . . .
Posted on 12/22/20
Gamida Cell Closes $75M Public Offering
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced that its previously . . .
Posted on 12/21/20
The Moderna Vaccine Arrives this Week in Maryland
Friday, has begun shipping to recipients in Maryland, Governor Larry Hogan announced today.Maryland’s total allotment now includes more than 191,000 total doses of the Pfizer and . . .
Posted on 12/21/20
Maryland’s Average Positivity Rate Remains Above 7% for Three Weeks
The seven-day average rate of coronavirus tests that have come back positive in Maryland has remained above 7% for 21 days.An average of 7.72% of the . . .
Posted on 12/21/20
Provention Bio Announces Addition to NASDAQ Biotechnology Index
Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it has been added to the NASDAQ Biotechnology . . .
Posted on 12/21/20
CapStone Holdings Invests $25 Million in Ilera Healthcare
CapStone Holdings, a business incubator and investment group, today announced a $25 million investment in TerrAscend's Ilera Healthcare Division, a vertically-integrated medical marijuana cultivator, processor, and . . .
Posted on 12/21/20
CVS Health Cash Tender Offers to an Aggregate Principal Amount of $4,500,000,000 from $4,000,000,000 of Certain Outstanding Notes
CVS Health Corporation announced today the early results of the previously announced cash tender offers and that it is amending the Tender Offers by increasing the . . .
Posted on 12/21/20
Servier to Acquire Agios Pharmaceuticals Oncology Business
Servier, a global pharmaceutical company, today announced that it has entered into an agreement for the acquisition of Agios Pharmaceuticals' oncology business including its commercial, clinical . . .
Posted on 12/21/20
Gabelli Healthcare & WellnessRx Trust Issues of $40 Million of 4.00% Series C Cumulative Preferred Shares
RYE, N.Y.--(BUSINESS WIRE)--The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) is pleased to announce the issuance of two million 4.00% Series C . . .
Posted on 12/21/20
Life Science Marketing Agency on Track for Record Year
Boston pharmaceutical marketing agency, ramarketing, will grow over 75pc this year due to surging global demand for the company’s industry expertise in drug development and manufacturing.The . . .
Posted on 12/21/20
Keros Therapeutics Announces Addition to NASDAQ Biotechnology Index
LEXINGTON, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments . . .
Posted on 12/21/20
Aileron Therapeutics Provides Business Update
WATERTOWN, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN) today provided a business update and outlined its strategic priorities for 2021, including announcing more . . .
Posted on 12/21/20
EyeGate Pharma Acquires Panoptes Pharma
EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), a clinical stage company focused on developing products for treating disorders of the eye, today announced the acquisition of Panoptes Pharma
Posted on 12/21/20
Va. Expects About 110,000 Fewer Doses of COVID-19 Vaccine Than Previously Announced
Virginia expects to receive 370,650 doses of the COVID-19 vaccines from Pfizer Inc. and Moderna by the end of the year instead of 480,000 as previously . . .
Posted on 12/21/20
CapStone Holdings Invests $25 Million in Ilera Healthcare
CapStone Holdings, a business incubator and investment group, today announced a $25 million investment in TerrAscend's Ilera Healthcare Division, a vertically-integrated medical marijuana cultivator, processor, and . . .
Posted on 12/21/20
Regenxbio: Championing Gene Therapy
SummaryBack in 2019, the Zolgensma approval validated Regenxbio's NAV technology platform for gene delivery. Despite a slow start, Zolgensma recently hit $1B in cumulative sales.Regenxbio's organic . . .
Posted on 12/21/20
Northwest Biotherapeutics: Blinded By The Dazzle Of The Unblinding
Summary NWBO has run an 18-year long trial in GBM, one of the deadliest of cancers.It has been mired in controversies, and it has no cash.Its . . .
Posted on 12/21/20
Where Will Novavax Be in 1 Year?
At the start of 2020, Novavax (NASDAQ:NVAX) shares were trading at $3.98, and the idea of a commercialized product seemed far off. Then two elements sent . . .
Posted on 12/21/20
Does Pfizer's Vaccine Authorization Improve Moderna's Chances?
Pfizer(NYSE:PFE) received U.S. Emergency Use Authorization (EUA) for its COVID-19 vaccine on Dec. 11, 2020. This has raised hopes that Moderna(NASDAQ:MRNA) could soon win EUA for . . .
Posted on 12/21/20
Did U.K. and Canadian Authorizations of Pfizer's COVID Vaccine Pressure the U.S.?
On Dec. 12, 2020, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to BNT162b2, the COVID-19 vaccine developed by Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) . . .
Posted on 12/21/20
Joe Biden to Receive First Dose of Pfizer/BioNTech Vaccine on Monday
The most high-profile American in 2021 is going to receive his initial dose of Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) coronavirus vaccine as 2020 fades away. President-Elect . . .
Posted on 12/21/20
Better Coronavirus Stock: Pfizer vs. BioNTech
Mercedes or Porsche? Steak or sushi? Two things can both be good but very different. For investors, the best coronavirus stock may depend on who's choosing. . . .
Posted on 12/21/20
Here's Why Pfizer's Vaccine Is So Important
Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) became the first drugmakers to win U.S. emergency use authorization for their COVID-19 vaccine BNT162b2 over the weekend. On Monday, the first Americans . . .

